Related references
Note: Only part of the references are listed.Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement
Vasileios Chortis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The Role of Surgery in the Management of Recurrent Adrenocortical Carcinoma
Ilknur Erdogan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Prevalence of Germline TP53 Mutations in a Prospective Series of Unselected Patients with Adrenocortical Carcinoma
Victoria M. Raymond et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Impact of Lymphadenectomy on the Oncologic Outcome of Patients With Adrenocortical Carcinoma
Joachim Reibetanz et al.
ANNALS OF SURGERY (2012)
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer
Marco Volante et al.
CLINICAL CANCER RESEARCH (2012)
Genetic aspects of adrenocortical tumours and hyperplasias
Tania L. Mazzuco et al.
CLINICAL ENDOCRINOLOGY (2012)
CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies
H. M. Zhang et al.
CLINICAL RADIOLOGY (2012)
Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients
Maria Candida B. V. Fragoso et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
[131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma
Stefanie Hahner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
Leonie J. M. Herrmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
Matthias Kroiss et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Operative management for recurrent and metastatic adrenocortical carcinoma
Nicole M. Datrice et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Association of adrenocortical carcinoma with familial cancer susceptibility syndromes
Tobias Else
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Recommendation for standardized surgical management of primary adrenocortical carcinoma
Sebastien Gaujoux et al.
SURGERY (2012)
Surgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery
Ilse G. C. Hermsen et al.
SURGERY (2012)
Preoperative 18F-FDG Uptake is Strongly Correlated with Malignancy, Weiss Score, and Molecular Markers of Aggressiveness in Adrenal Cortical Tumors
Lucile Gust et al.
WORLD JOURNAL OF SURGERY (2012)
Liver Resection and Ablation for Metastatic Adrenocortical Carcinoma
R. Taylor Ripley et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Pulmonary Resection for Metastatic Adrenocortical Carcinoma: The National Cancer Institute Experience
Clinton D. Kemp et al.
ANNALS OF THORACIC SURGERY (2011)
Metastatic Adrenocortical Carcinoma: Results of 56 Pulmonary Metastasectomies in 24 Patients
Jan Op den Winkel et al.
ANNALS OF THORACIC SURGERY (2011)
β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma
Sebastien Gaujoux et al.
CLINICAL CANCER RESEARCH (2011)
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
Matthias Kroiss et al.
CLINICAL ENDOCRINOLOGY (2011)
Contemporary Management of Adrenocortical Carcinoma
Laurent Zini et al.
EUROPEAN UROLOGY (2011)
ADJUVANT AND DEFINITIVE RADIOTHERAPY FOR ADRENOCORTICAL CARCINOMA
Aaron Sabolch et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study
Ilse G. Hermsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
Wiebke Arlt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Adrenocortical carcinoma: a clinician's update
Martin Fassnacht et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Characterization of Adrenal Masses by Using FDG PET: A Systematic Review and Meta-Analysis of Diagnostic Test Performance
Giles W. L. Boland et al.
RADIOLOGY (2011)
Metomidate-Based Imaging of Adrenal Masses
S. Hahner et al.
Hormones & Cancer (2011)
FDG PET in the Management of Patients with Adrenal Masses and Adrenocortical Carcinoma
Désirée Deandreis et al.
Hormones & Cancer (2011)
A debate on laparoscopic versus open adrenalectomy for adrenocortical carcinoma
Francesco Porpiglia et al.
Hormones & Cancer (2011)
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
Paul Haluska et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome
Edenir I. Palmero et al.
CURRENT OPINION IN ONCOLOGY (2010)
SUSTAINED REMISSION WITH THE KINASE INHIBITOR SORAFENIB IN STAGE IV METASTATIC ADRENOCORTICAL CARCINOMA
Charles Butler et al.
ENDOCRINE PRACTICE (2010)
Therapeutic Concentrations of Mitotane (o,p '-DDD) Inhibit Thyrotroph Cell Viability and TSH Expression and Secretion in a Mouse Cell Line Model
Maria Chiara Zatelli et al.
ENDOCRINOLOGY (2010)
Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients
David Brix et al.
EUROPEAN UROLOGY (2010)
Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer
Francesco Porpiglia et al.
EUROPEAN UROLOGY (2010)
Approach to the Patient with Adrenocortical Carcinoma
Andre Lacroix
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers
Martin Fassnacht et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel
Alfredo Berruti et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
Thomas J. Giordano et al.
CLINICAL CANCER RESEARCH (2009)
Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma
Ferdous M. Barlaskar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival
Aurelien de Reynies et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors
G. Masi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Treatment of advanced Adrenocortical carcinoma with erlotinib plus gemcitabine
Marcus Quinkler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Molecular basis of the Li-Fraumeni syndrome:: an update from the French LFS families
G. Bougeard et al.
JOURNAL OF MEDICAL GENETICS (2008)
Adjuvant mitotane treatment for adrenocortical carcinoma
Massimo Terzolo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma
Martin Fassnacht et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Use of [18F] fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma
Gavin C. Mackie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings
J Hennings et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma:: A prospective comparison with computed tomography
S Leboulleux et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Management of patients with adrenal cancer: recommendations of an international consensus conference
DE Schteingart et al.
ENDOCRINE-RELATED CANCER (2005)
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
A Berruti et al.
ENDOCRINE-RELATED CANCER (2005)
Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients:: Long-term survival in its adjuvant use
TS Khan et al.
ANNALS OF ONCOLOGY (2000)
Share Paper
